Ignite Creation Date:
2024-05-05 @ 9:25 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00883298
Status:
COMPLETED
Last Update Posted:
2017-03-30
First Post:
2009-04-16
Brief Title:
Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
Sponsor:
Center for Neurosciences Tucson
Organization:
Center for Neurosciences Tucson
Organization Data
Organization:
Center for Neurosciences Tucson
Class:
OTHER
Study ID:
AVF4514s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Center for Neurosciences Tucson
Lead Sponsor Class:
OTHER
Responsible Party:
Michael Badruddoja MD
Responsible Party Title:
Neurologist NeuroOncologist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Center for Neurosciences Tucson
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |